Ushbu ish iqtibos qilgan ishlar

42 ta ish

Ish: The Use of Nivolumab in Colorectal Cancer with Lynch Syndrome. A Case Report

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang +32
Maqola20155 iqtibos
ABI
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong +17
Maqola20183 iqtibos
ABI
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith +43
Maqola20172 iqtibos
ABI
Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer
John M. Carethers
Sharh maqola20152 iqtibos
ABI
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Fay Kastrinos
Maqola20092 iqtibos
ABI
Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II)
Henry T. Lynch, Patrice Watson, Stephen J. Lanspa +5
Maqola19882 iqtibos
ABI
Screening for hereditary non-polyposis colorectal cancer: A study of 22 kindreds in The Netherlands
Hans F. A. Vasen, Frieda C. A. den Hartog Jager, Fred H. Menko +1
Maqola19892 iqtibos
ABI
Inheritance of colorectal cancer
Randall W. Burt
Maqola20072 iqtibos
ABI
Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC)
Hye-Jung Han, Masakazu Maruyama, Shozo Baba +2
Maqola19952 iqtibos
ABI
Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations
Patrick Joost, Christina Therkildsen, Mev Dominguez–Valentin +2
Maqola20152 iqtibos
ABI
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
Hans F. A. Vasen, Jukka‐Pekka Mecklin, P. Meera Khan +1
Maqola19912 iqtibos
ABI
Lynch syndrome in the 21st century: clinical perspectives
Ashish K. Tiwari, Hemant K. Roy, H. T. Lynch
Sharh maqola20152 iqtibos
ABI
Cancer Risks Associated With Germline Mutations in <emph type="ital">MLH1</emph>, <emph type="ital">MSH2</emph>, and <emph type="ital">MSH6</emph> Genes in Lynch Syndrome
Valérie Bonadona
Maqola20112 iqtibos
ABI
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pål Møller, Toni T. Seppälä, Inge Bernstein +33
Maqola20152 iqtibos
ABI
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs +15
Maqola20172 iqtibos
ABI
Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)
Heinz‐Josef Lenz, Eric Van Cutsem, María Luisa Limón +15
Maqola20182 iqtibos
ABI
Tumor Testing for Microsatellite Instability to Identify Lynch Syndrome: New Insights Into an Old Diagnostic Strategy
Matthew B. Yurgelun, Fay Kastrinos
Boshqa20182 iqtibos
ABI
Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine
Laura Valle, Eduardo Vilar, Sean V. Tavtigian +1
Sharh maqola20182 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI